Inducible Nitric Oxide Synthase is Not Essential for Control of Trypanosoma Cruzi Infection in Mice

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2004 Jun 24

PMID 15213153

Citations 27

Authors

Kara L Cummings

Rick L Tarleton

Affiliations

Soon will be listed here.

Abstract

Immune control of many intracellular pathogens, including Trypanosoma cruzi, is reported to be dependent on the production of nitric oxide. In this study, we show that mice deficient in inducible nitric oxide synthase (iNOS or NOS2) exhibit resistance to T. cruzi infection that is comparable to that of wild-type mice. This is the case for two iNOS-deficient mouse strains, Nos2(tm1Lau) and Nos2 N5, infected with the Brazil or Tulahuen strain of T. cruzi. In all cases, blood parasitemia, tissue parasite load, and survival rates are similar between wild-type and iNOS-deficient mice. In contrast, both wild-type and Nos2(tm1Lau) mice died within 32 days postinfection when treated with the nitric oxide synthase inhibitor aminoguanidine. Increased transcription of NOS1 or NOS3 is not found in iNOS-knockout (KO) mice, indicating that the absence of nitric oxide production through iNOS is not compensated for by increased production of other NOS isoforms. However, Nos2(tm1Lau) mice exhibit enhanced expression of tumor necrosis factor alpha, interleukin-1, and macrophage inflammatory protein 1alpha compared to that of wild-type mice, and these alterations may in part compensate for the lack of iNOS. These results clearly show that iNOS is not required for control of T. cruzi infection in mice.

Citing Articles

Animal models for exploring Chagas disease pathogenesis and supporting drug discovery.

Khan A, Taylor M, Fortes Francisco A, Jayawardhana S, Atherton R, Olmo F Clin Microbiol Rev. 2024; 37(4):e0015523.

PMID: 39545730 PMC: 11629624. DOI: 10.1128/cmr.00155-23.

Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy.

Nunes J, Roda V, Andrieux P, Kalil J, Chevillard C, Cunha-Neto E Exp Biol Med (Maywood). 2024; 248(22):2062-2071.

PMID: 38235691 PMC: 10800136. DOI: 10.1177/15353702231220658.

Modulation of STAT-1, STAT-3, and STAT-6 activities in THP-1 derived macrophages infected with two strains.

Oliveira M, Bonturi C, Salu B, Oliva M, Mortara R, Orikaza C Front Immunol. 2022; 13:1038332.

PMID: 36389843 PMC: 9643828. DOI: 10.3389/fimmu.2022.1038332.

IFN-induced cell-autonomous immune mechanisms in the control of intracellular protozoa.

Skariah S, Sultan A, Mordue D Parasitol Res. 2022; 121(6):1559-1571.

PMID: 35435512 PMC: 9206464. DOI: 10.1007/s00436-022-07514-7.

Predicting Blood Parasite Load and Influence of Expression of iNOS on the Effect Size of Clinical Laboratory Parameters in Acute Infection With Different Inoculum Concentrations in C57BL/6 Mice.

Rodrigues W, Miguel C, Marques L, Da Costa T, Abreu M, Oliveira C Front Immunol. 2022; 13:850037.

PMID: 35371021 PMC: 8974915. DOI: 10.3389/fimmu.2022.850037.

References

Schroder K, Hertzog P, Ravasi T, Hume D . Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2003; 75(2):163-89. DOI: 10.1189/jlb.0603252. View

Bieganski T, Kusche J, Lorenz W, Hesterberg R, Stahlknecht C, Feussner K . Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolism. Biochim Biophys Acta. 1983; 756(2):196-203. DOI: 10.1016/0304-4165(83)90092-2. View

Seiler N, Bolkenius F, Knodgen B . The influence of catabolic reactions on polyamine excretion. Biochem J. 1985; 225(1):219-26. PMC: 1144572. DOI: 10.1042/bj2250219. View

Hibbs Jr J, Vavrin Z, Taintor R . L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 1987; 138(2):550-65. View

Hibbs Jr J, Taintor R, Vavrin Z . Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. Science. 1987; 235(4787):473-6. DOI: 10.1126/science.2432665. View

Brownlee M, Cerami A, Vlassara H . Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 318(20):1315-21. DOI: 10.1056/NEJM198805193182007. View

Reed S . In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J Immunol. 1988; 140(12):4342-7. View

Ding A, Nathan C, Stuehr D . Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 1988; 141(7):2407-12. View

Moser D, Kirchhoff L, Donelson J . Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol. 1989; 27(7):1477-82. PMC: 267598. DOI: 10.1128/jcm.27.7.1477-1482.1989. View

10.

Green S, Meltzer M, Hibbs Jr J, Nacy C . Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol. 1990; 144(1):278-83. View

11.

Tarleton R . Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J Immunol. 1990; 144(2):717-24. View

12.

Adams L, Hibbs Jr J, Taintor R, Krahenbuhl J . Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990; 144(7):2725-9. View

13.

Kilbourn R, Belloni P . Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst. 1990; 82(9):772-6. DOI: 10.1093/jnci/82.9.772. View

14.

Khan I, Schwartzman J, Matsuura T, Kasper L . A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. Proc Natl Acad Sci U S A. 1998; 94(25):13955-60. PMC: 28414. DOI: 10.1073/pnas.94.25.13955. View

15.

Low H, Santos M, Wizel B, Tarleton R . Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. J Immunol. 1998; 160(4):1817-23. View

16.

Holscher C, Kohler G, Muller U, Mossmann H, Schaub G, Brombacher F . Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun. 1998; 66(3):1208-15. PMC: 108035. DOI: 10.1128/IAI.66.3.1208-1215.1998. View

17.

Camargo M, Andrade A, Almeida I, Travassos L, Gazzinelli R . Glycoconjugates isolated from Trypanosoma cruzi but not from Leishmania species membranes trigger nitric oxide synthesis as well as microbicidal activity in IFN-gamma-primed macrophages. J Immunol. 1998; 159(12):6131-9. View

18.

Olivares Fontt E, De Baetselier P, Heirman C, Thielemans K, Lucas R, Vray B . Effects of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha on Trypanosoma cruzi trypomastigotes. Infect Immun. 1998; 66(6):2722-7. PMC: 108261. DOI: 10.1128/IAI.66.6.2722-2727.1998. View

19.

Kumar S, Tarleton R . The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol. 1998; 20(5):207-16. DOI: 10.1046/j.1365-3024.1998.00154.x. View

20.

Karupiah G, Chen J, Mahalingam S, Nathan C, MacMicking J . Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med. 1998; 188(8):1541-6. PMC: 2213404. DOI: 10.1084/jem.188.8.1541. View